[{"AccountsPayableCurrent_0_Q1_USD":7910000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":456000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q1_shares":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7203000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":31110000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":673313000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":46.44,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-2087000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-2087000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":18000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-128827000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1153000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":51908760.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":3369397.0,"OtherAssetsNoncurrent_0_Q1_USD":3694000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":15000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":12685993.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":155000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":7789000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2620700000.0,"MarketableSecuritiesCurrent_0_Q1_USD":673313000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":4729000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":30218000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":2793000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2367000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":275197000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":3160000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":68651000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-2087000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":31992000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":24951000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":10270000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-99000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-35391000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":72739000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":201811000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":199444000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":673313000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":674105000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":2098000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1306000.0,"AssetsFairValueDisclosure_0_Q1_USD":872757000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":13852000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":5168000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":51908760.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":367000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-136691000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":206270000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3160000.0,"LiabilitiesCurrent_0_Q1_USD":70360000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":944973000.0,"Liabilities_0_Q1_USD":95767000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1221000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-7307000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.44,"Depreciation_1_Q1_USD":669000.0,"CommonStockValue_0_Q1_USD":5000.0,"CommonStockSharesOutstanding_0_Q1_shares":51917819.0,"CommonStockSharesIssued_0_Q1_shares":51920852.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":199444000.0,"AssetsCurrent_0_Q1_USD":898236000.0,"Assets_0_Q1_USD":944973000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8180719.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-792000.0,"NetIncomeLoss_1_Q1_USD":-126740000.0,"TreasuryStockCommonShares_0_Q1_shares":3033.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":276000.0,"ProfitLoss_1_Q1_USD":-126740000.0,"ShareBasedCompensation_1_Q1_USD":31110000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":70130000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":63610000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-131624000.0,"OperatingExpenses_1_Q1_USD":133910000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":52180000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51908760.0,"StockholdersEquity_0_Q1_USD":849206000.0,"Revenues_1_Q1_USD":2286000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1770307000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8684000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":25479000.0,"TreasuryStockCommonValue_0_Q1_USD":400000.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]